Atıf Formatları
Azacitidine versus decitabine in patients with refractory anemia with excess blast-Results of multicenter study.
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

O. Salim Et Al. , "Azacitidine versus decitabine in patients with refractory anemia with excess blast-Results of multicenter study.," Leukemia research , vol.45, pp.82-9, 2016

Salim, O. Et Al. 2016. Azacitidine versus decitabine in patients with refractory anemia with excess blast-Results of multicenter study.. Leukemia research , vol.45 , 82-9.

Salim, O., Toptas, T., Avsar, E., Yucel, O. K., Ozturk, E., Ferhanoglu, B., ... Geduk, A.(2016). Azacitidine versus decitabine in patients with refractory anemia with excess blast-Results of multicenter study.. Leukemia research , vol.45, 82-9.

Salim, OZAN Et Al. "Azacitidine versus decitabine in patients with refractory anemia with excess blast-Results of multicenter study.," Leukemia research , vol.45, 82-9, 2016

Salim, OZAN Et Al. "Azacitidine versus decitabine in patients with refractory anemia with excess blast-Results of multicenter study.." Leukemia research , vol.45, pp.82-9, 2016

Salim, O. Et Al. (2016) . "Azacitidine versus decitabine in patients with refractory anemia with excess blast-Results of multicenter study.." Leukemia research , vol.45, pp.82-9.

@article{article, author={OZAN SALİM Et Al. }, title={Azacitidine versus decitabine in patients with refractory anemia with excess blast-Results of multicenter study.}, journal={Leukemia research}, year=2016, pages={82-9} }